hrcak mascot   Srce   HID

Pregledni rad
https://doi.org/10.21860/52;3_357

The role of the pathologist in diagnosis and therapy of the breast cancer patients

Elvira Mustać ; Zavod za patologiju i patološku anatomiju, Medicinski fakultet Sveučilišta u Rijeci, Rijeka
Nives Jonjić ; Zavod za patologiju i patološku anatomiju, Medicinski fakultet Sveučilišta u Rijeci, Rijeka
Koraljka Rajković Molek ; Zavod za kliničku citologiju, KBC Rijeka,
Manuela Avirović ; Zavod za patologiju i patološku anatomiju, Medicinski fakultet Sveučilišta u Rijeci, Rijeka

Puni tekst: hrvatski, pdf (1 MB) str. 357-361 preuzimanja: 1.328* citiraj
APA 6th Edition
Mustać, E., Jonjić, N., Rajković Molek, K. i Avirović, M. (2016). Uloga patologa u dijagnostici i terapiji pacijenata s karcinomom dojke. Medicina Fluminensis, 52 (3), 357-361. https://doi.org/10.21860/52;3_357
MLA 8th Edition
Mustać, Elvira, et al. "Uloga patologa u dijagnostici i terapiji pacijenata s karcinomom dojke." Medicina Fluminensis, vol. 52, br. 3, 2016, str. 357-361. https://doi.org/10.21860/52;3_357. Citirano 01.12.2020.
Chicago 17th Edition
Mustać, Elvira, Nives Jonjić, Koraljka Rajković Molek i Manuela Avirović. "Uloga patologa u dijagnostici i terapiji pacijenata s karcinomom dojke." Medicina Fluminensis 52, br. 3 (2016): 357-361. https://doi.org/10.21860/52;3_357
Harvard
Mustać, E., et al. (2016). 'Uloga patologa u dijagnostici i terapiji pacijenata s karcinomom dojke', Medicina Fluminensis, 52(3), str. 357-361. https://doi.org/10.21860/52;3_357
Vancouver
Mustać E, Jonjić N, Rajković Molek K, Avirović M. Uloga patologa u dijagnostici i terapiji pacijenata s karcinomom dojke. Medicina Fluminensis [Internet]. 2016 [pristupljeno 01.12.2020.];52(3):357-361. https://doi.org/10.21860/52;3_357
IEEE
E. Mustać, N. Jonjić, K. Rajković Molek i M. Avirović, "Uloga patologa u dijagnostici i terapiji pacijenata s karcinomom dojke", Medicina Fluminensis, vol.52, br. 3, str. 357-361, 2016. [Online]. https://doi.org/10.21860/52;3_357

Sažetak
Histopathological features of breast cancer include numerous details that are essential for the further choice of patient’s therapy because it must be clear, unambiguously stated and reliable. In addition to traditional data on invasion, metastasis and response to therapy more information on prognostic and predictive factors that affect the treatment provide patients and genetic research on the basis of which tumors according to the expression of certain genes in the stratified subtypes.

Ključne riječi
breast cancer; molecular typing; prognostic and predictive factors *

Hrčak ID: 163941

URI
https://hrcak.srce.hr/163941

[hrvatski]

Posjeta: 1.572 *